Literature DB >> 12692304

Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2.

Rebekah R White1, Siqing Shan, Christopher P Rusconi, Geetha Shetty, Mark W Dewhirst, Christopher D Kontos, Bruce A Sullenger.   

Abstract

Angiopoietin-2 (Ang2) appears to be a naturally occurring antagonist of the endothelial receptor tyrosine kinase Tie2, an important regulator of vascular stability. Destabilization of the endothelium by Ang2 is believed to potentiate the actions of proangiogenic growth factors. To investigate the specific role of Ang2 in the adult vasculature, we generated a nuclease-resistant RNA aptamer that binds and inhibits Ang2 but not the related Tie2 agonist, angiopoietin-1. Local delivery of this aptamer but not a partially scrambled mutant aptamer inhibited basic fibroblast growth factor-mediated neovascularization in the rat corneal micropocket angiogenesis assay. These in vivo data directly demonstrate that a specific inhibitor of Ang2 can act as an antiangiogenic agent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692304      PMCID: PMC154292          DOI: 10.1073/pnas.0831159100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Intimal hyperplasia recurs after removal of PDGF-AB and -BB inhibition in the rat carotid artery injury model.

Authors:  O Leppänen; N Janjic; M A Carlsson; K Pietras; M Levin; C Vargeese; L S Green; D Bergqvist; A Ostman; C H Heldin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

2.  Generation of species cross-reactive aptamers using "toggle" SELEX.

Authors:  R White; C Rusconi; E Scardino; A Wolberg; J Lawson; M Hoffman; B Sullenger
Journal:  Mol Ther       Date:  2001-12       Impact factor: 11.454

Review 3.  Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results.

Authors:  R S Kerbel
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

4.  Heterogeneous vascular dependence of tumor cell populations.

Authors:  J L Yu; J W Rak; P Carmeliet; A Nagy; R S Kerbel; B L Coomber
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

5.  Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis.

Authors:  S A Ahmad; W Liu; Y D Jung; F Fan; N Reinmuth; C D Bucana; L M Ellis
Journal:  Cancer       Date:  2001-09-01       Impact factor: 6.860

6.  The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.

Authors:  S Shan; A C Lockhart; W Y Saito; A M Knapp; K R Laderoute; M W Dewhirst
Journal:  Clin Cancer Res       Date:  2001-08       Impact factor: 12.531

7.  Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization.

Authors:  J K Chae; I Kim; S T Lim; M J Chung; W H Kim; H G Kim; J K Ko; G Y Koh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

8.  Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity.

Authors:  W N Procopio; P I Pelavin; W M Lee; N M Yeilding
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

9.  Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.

Authors:  T Etoh; H Inoue; S Tanaka; G F Barnard; S Kitano; M Mori
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

10.  Expression and function of angiopoietin-1 in breast cancer.

Authors:  A J Hayes; W Q Huang; J Yu; P C Maisonpierre; A Liu; F G Kern; M E Lippman; S W McLeskey; L Y Li
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

View more
  50 in total

1.  Development of DNA aptamers using Cell-SELEX.

Authors:  Kwame Sefah; Dihua Shangguan; Xiangling Xiong; Meghan B O'Donoghue; Weihong Tan
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

Review 2.  [Viral and nonviral gene therapy for treatment of retinal diseases].

Authors:  J Neidhardt; K Wycisk; B Klöckener-Gruissem
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

3.  A mathematical analysis of SELEX.

Authors:  Howard A Levine; Marit Nilsen-Hamilton
Journal:  Comput Biol Chem       Date:  2007-01-10       Impact factor: 2.877

4.  Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage.

Authors:  Janka Kisucka; Catherine E Butterfield; Dan G Duda; Sarah C Eichenberger; Simin Saffaripour; Jerry Ware; Zaverio M Ruggeri; Rakesh K Jain; Judah Folkman; Denisa D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

Review 5.  Molecular aptamers for drug delivery.

Authors:  Weihong Tan; Hui Wang; Yan Chen; Xiaobing Zhang; Haizhen Zhu; Chaoyong Yang; Ronghua Yang; Chen Liu
Journal:  Trends Biotechnol       Date:  2011-08-06       Impact factor: 19.536

Review 6.  Clinical correlates of common corneal neovascular diseases: a literature review.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Amira A Zayed; Hamdy Salem; Ahmed E Elkhanany; Heba Hussein; Nawal Abd El-Baky
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

7.  A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization.

Authors:  G M Palmer; Z Tiran; Z Zhou; M E Capozzi; W Park; C Coletta; A Pyriochou; Y Kliger; O Levy; I Borukhov; M W Dewhirst; G Rotman; J S Penn; A Papapetropoulos
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

8.  A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor.

Authors:  Roselyne Tournaire; Marie-Pierre Simon; Ferdinand le Noble; Anne Eichmann; Patrick England; Jacques Pouysségur
Journal:  EMBO Rep       Date:  2004-02-20       Impact factor: 8.807

Review 9.  Angiopoietin-2: development of inhibitors for cancer therapy.

Authors:  Bo Hu; Shi-Yuan Cheng
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

10.  Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

Authors:  Peng Chen; Hongmei Yin; Yao Wang; Jing Mi; Wenxiao He; Lixin Xie; Yiqiang Wang
Journal:  Mol Vis       Date:  2010-02-27       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.